Clinical Trial Update: Hydroxychloroquine in Mild Graves' Orbitopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating hydroxychloroquine for mild Graves' ophthalmopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Graves Ophthalmopathy | Phase 4 | Status: RECRUITING